Hong Kan

2.6k total citations
79 papers, 2.0k citations indexed

About

Hong Kan is a scholar working on Cardiology and Cardiovascular Medicine, Rheumatology and Physiology. According to data from OpenAlex, Hong Kan has authored 79 papers receiving a total of 2.0k indexed citations (citations by other indexed papers that have themselves been cited), including 21 papers in Cardiology and Cardiovascular Medicine, 15 papers in Rheumatology and 13 papers in Physiology. Recurrent topics in Hong Kan's work include Systemic Lupus Erythematosus Research (14 papers), Pharmacology and Obesity Treatment (9 papers) and Diabetes Treatment and Management (8 papers). Hong Kan is often cited by papers focused on Systemic Lupus Erythematosus Research (14 papers), Pharmacology and Obesity Treatment (9 papers) and Diabetes Treatment and Management (8 papers). Hong Kan collaborates with scholars based in United States, United Kingdom and Japan. Hong Kan's co-authors include Mitchell S. Finkel, Xiaoqing He, Qiang Ma, Lu Cai, C. Molta, Nadia N. Ahmad, Vincent Castranova, Bimal V. Patel, Randa Eldessouki and Andrew Briggs and has published in prestigious journals such as Journal of Biological Chemistry, SHILAP Revista de lepidopterología and PLoS ONE.

In The Last Decade

Hong Kan

75 papers receiving 1.9k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Hong Kan United States	26	410	390	280	270	242	79	2.0k
Yun Kyu Oh South Korea	29	269 0.7×	646 1.7×	177 0.6×	319 1.2×	202 0.8×	147	2.8k
Tanqi Lou China	27	281 0.7×	509 1.3×	175 0.6×	488 1.8×	146 0.6×	93	2.3k
Chang Seong Kim South Korea	32	153 0.4×	556 1.4×	209 0.7×	543 2.0×	235 1.0×	220	3.2k
Philip Masson Australia	20	274 0.7×	459 1.2×	204 0.7×	592 2.2×	390 1.6×	47	4.1k
Dahai Yu United Kingdom	29	266 0.6×	416 1.1×	100 0.4×	389 1.4×	551 2.3×	142	2.5k
Susanne B. Nicholas United States	30	170 0.4×	792 2.0×	119 0.4×	509 1.9×	463 1.9×	87	2.8k
Kwon Wook Joo South Korea	32	274 0.7×	762 2.0×	255 0.9×	469 1.7×	354 1.5×	268	4.3k
Melanie M. van der Klauw Netherlands	28	188 0.5×	209 0.5×	80 0.3×	194 0.7×	652 2.7×	90	2.2k
Antonio Muscari Italy	28	225 0.5×	474 1.2×	433 1.5×	698 2.6×	335 1.4×	88	2.8k
Sophie Liabeuf France	33	245 0.6×	827 2.1×	197 0.7×	559 2.1×	396 1.6×	143	4.6k

Countries citing papers authored by Hong Kan

Since Specialization

Citations

This map shows the geographic impact of Hong Kan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hong Kan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hong Kan more than expected).

Fields of papers citing papers by Hong Kan

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Hong Kan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hong Kan. The network helps show where Hong Kan may publish in the future.

Co-authorship network of co-authors of Hong Kan

This figure shows the co-authorship network connecting the top 25 collaborators of Hong Kan. A scholar is included among the top collaborators of Hong Kan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hong Kan. Hong Kan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Done, Nicolae, Alan Brnabic, Ilya Lipkovich, et al.. (2026). Comparative effectiveness of tirzepatide and semaglutide for obesity management in US clinical practice: a 6-month retrospective cohort study. Journal of Endocrinological Investigation. 49(2). 413–423.

Kan, Hong, et al.. (2025). Modeling potential cost‐effectiveness of tirzepatide versus lifestyle modification for patients with overweight and obesity. Obesity. 33(7). 1297–1308.

Choong, Casey, Beverly L. Falcón, Hong Kan, et al.. (2025). Identifying individuals at risk for weight gain using machine learning in electronic medical records from the United States. Diabetes Obesity and Metabolism. 27(6). 3061–3071.

Gudzune, Kimberly A., Lee M. Kaplan, Scott Kahan, et al.. (2024). Weight-Reduction Preferences Among OBSERVE Study Participants With Obesity or Overweight: Opportunities for Shared Decision-Making. Endocrine Practice. 30(10). 917–926. 3 indexed citations

Choong, Casey, et al.. (2024). Applying machine learning approaches for predicting obesity risk using US health administrative claims database. BMJ Open Diabetes Research & Care. 12(5). e004193–e004193. 4 indexed citations

Fedan, Jeffrey S., Janet A. Thompson, Tina M. Sager, et al.. (2024). Toxicological Effects of Inhaled Crude Oil Vapor. Current Environmental Health Reports. 11(1). 18–29. 2 indexed citations

Franek, Edward, Prem Pais, Jan Basile, et al.. (2023). General versus central adiposity as risk factors for cardiovascular-related outcomes in a high-risk population with type 2 diabetes: a post hoc analysis of the REWIND trial. Cardiovascular Diabetology. 22(1). 52–52. 16 indexed citations

Kan, Hong, Jay Bae, Julia P. Dunn, et al.. (2023). Real-world primary nonadherence to antiobesity medications. Journal of Managed Care & Specialty Pharmacy. 29(10). 1099–1108. 8 indexed citations

Hankosky, Emily R., Hui Wang, Lisa M. Neff, et al.. (2023). Tirzepatide reduces the predicted risk of developing type 2 diabetes in people with obesity or overweight: Post hoc analysis of the SURMOUNT ‐1 trial. Diabetes Obesity and Metabolism. 25(12). 3748–3756. 25 indexed citations

10.

Roux, Carel W. le, Emily R. Hankosky, Raleigh Malik, et al.. (2023). Tirzepatide 10 and 15 mg compared with semaglutide 2.4 mg for the treatment of obesity: An indirect treatment comparison. Diabetes Obesity and Metabolism. 25(9). 2626–2633. 25 indexed citations

11.

Turchin, Alexander, Fritha Morrison, Maria Shubina, et al.. (2023). EXIST: EXamining rIsk of excesS adiposiTy—Machine learning to predict obesity‐related complications. Obesity Science & Practice. 10(1). e707–e707. 4 indexed citations

12.

Lin, Dora H., Irene B. Murimi, Hong Kan, et al.. (2022). Health care utilization and costs of systemic lupus erythematosus in the United States: A systematic review. Lupus. 31(7). 773–807. 6 indexed citations

13.

MacEwan, Joanna P., et al.. (2021). Antiobesity Medication Use Among Overweight and Obese Adults in the United States: 2015–2018. Endocrine Practice. 27(11). 1139–1148. 28 indexed citations

14.

Murimi, Irene B., Dora H. Lin, Henk Nab, et al.. (2020). Association between organ damage and mortality in systemic lupus erythematosus: a systematic review and meta-analysis. BMJ Open. 10(5). e031850–e031850. 63 indexed citations

15.

Krajnak, Kristine, Hong Kan, Walter McKinney, et al.. (2020). Biological effects of inhaled hydraulic fracturing sand dust. VI. Cardiovascular effects. Toxicology and Applied Pharmacology. 406. 115242–115242. 10 indexed citations

16.

Roberts, Jenny R., Stacey E. Anderson, Hong Kan, et al.. (2015). Evaluation of Pulmonary and Systemic Toxicity of Oil Dispersant (COREXIT EC9500A®) Following Acute Repeated Inhalation Exposure. SHILAP Revista de lepidopterología. 3 indexed citations

17.

Antonini, James M., Yen‐Chang Lin, Jenny R. Roberts, et al.. (2015). Cardiovascular effects in rats after intratracheal instillation of metal welding particles. Inhalation Toxicology. 27(1). 45–53. 15 indexed citations

18.

Ke, Xuehua, et al.. (2015). A Retrospective Administrative Claims Database Evaluation of the Utilization of Belimumab in US Managed Care Settings. Clinical Therapeutics. 37(12). 2852–2863. 12 indexed citations

19.

Beezhold, Kevin, Jia Liu, Hong Kan, et al.. (2011). miR-190-Mediated Downregulation of PHLPP Contributes to Arsenic-Induced Akt Activation and Carcinogenesis. Toxicological Sciences. 123(2). 411–420. 88 indexed citations

20.

Kan, Hong & Mitchell S. Finkel. (2003). Inflammatory mediators and reversible myocardial dysfunction. Journal of Cellular Physiology. 195(1). 1–11. 28 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact